Sarepta Therapeutics: Q4 Earnings Snapshot

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Sarepta Therapeutics Inc. (SRPT) on Tuesday reported a loss of $109.2 million in its fourth quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $1.24.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.28 per share.

The biopharmaceutical company posted revenue of $258.4 million in the period, also topping Street forecasts. Five analysts surveyed by Zacks expected $249.4 million.

For the year, the company reported a loss of $703.5 million, or $8.03 per share. Revenue was reported as $933 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on SRPT at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up